Evotec SE

Stocks

Market Closed - Xetra 01:37:13 20/08/26 am AEST			5-day change	1st Jan Change
3.404 ^EUR	+2.53%		-8.15%	-37.54%

13/08	Energiekontor hits March low, doubts over a strong second half	DP
13/08	Evotec's final first-half results once again spook investors	DP

Published on 03/11/2026 at 09:22 am AEDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, welcome to the Evotec SE Analyst and Investors Conference Call and Live Webcast. I am [ Moira ], the Chorus Call operator.

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Full unlimited browsing across the entire site

Access to all the news and all the data

Access to US, EUROPE AND ASIA Portfolios

Zero Ads for a completely uninterrupted reading experience

Pro Tools: Expert insights, Expert Screeners, historical financial data and reports, thematic lists, transcripts...

13/08	Energiekontor hits March low, doubts over a strong second half	DP
13/08	Evotec's final first-half results once again spook investors	DP
13/08	Evotec SE Reports Earnings Results for the Half Year Ended June 30, 2026	CI
13/08	Evotec SE : Gets a Buy rating from RBC	ZD
13/08	Evotec Se Announces Camilla Macapili Languille Step Down as Supervisory Board, Effective August 7, 2026	CI
13/08	Evotec Se Reaffirms Earnings Guidance for the Full-Year 2026	CI
06/08	Evotec, Odyssey Therapeutics Partner to Develop Autoimmune, Inflammatory Disease Treatments	MT
06/08	Evotec, Odyssey Therapeutics Team Up on Autoimmune, Inflammatory Disease Treatment Research	MT
06/08	Evotec Se and Odyssey Therapeutics, Inc. Enter Ai-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases	CI
04/08	Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168	CI
03/08	Niagen Bioscience, Evotec to Advance Preclinical Development of NB4168	MT
23/07	Navan Selected by Evotec for Global Travel, Expense Management	MT
16/07	Berenberg Downgrades Evotec to Hold From Buy, Cuts Price Target to EUR3.60 From EUR9.40	MT
16/07	EVOTEC : Deutsche Bank reaffirms its Neutral rating	ZD
16/07	EVOTEC : Reduced to Neutral by Berenberg	ZD